Average Co-Inventor Count = 4.12
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neurosearch A/s (26 from 206 patents)
2. Aniona Aps (1 from 5 patents)
3. Abbott Laboratories Corporation (4,177 patents)
27 patents:
1. 9133184 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
2. 8410271 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
3. 8343960 - 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
4. 8110586 - 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
5. 8049012 - 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
6. 7989470 - 3,8-substituted 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
7. 7943630 - 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
8. 7935695 - 1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands
9. 7855208 - 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists
10. 7329754 - 2,5-diazabicyclo[2.2.1]heptane derivatives
11. 7314870 - Compounds, their preparation and use
12. 7282494 - Heteroaryl diazacycloalkanes, their preparation and use
13. 7064118 - Heteroaryl diazacycloalkanes, their preparation and use
14. 7045522 - 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field
15. 6964972 - 8-Azabicyclo(3,2,1)oct-2 ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors